Intrauterine transfusion of a hydropic fetus with anemia due to a giant chorioangioma: A case report

Eur J Obstet Gynecol Reprod Biol. 2022 Nov:278:122-124. doi: 10.1016/j.ejogrb.2022.09.010. Epub 2022 Sep 13.

Abstract

Giant chorioangiomas are a potentially life-threatening condition that may require intrauterine therapy. We describe a case of a large chorioangioma (>4cm) diagnosed at 30 weeks of gestation causing severe fetal anemia and hydrops. An intrauterine blood transfusion was performed at 31 weeks with reversal of the anemia and hydrops. The neonate was born at 37 weeks showing respiratory distress syndrome that required neonatal intensive care unit admission but was discharged at 30 days of life. Further evaluation at two months of age showed no signs of abnormal neurodevelopment. When timely indicated, intrauterine transfusion of a hydropic fetus with anemia due to a giant chorioangioma is a potentially life-saving therapy that shows good neurodevelopment of the surviving fetus.

Keywords: Chorioangioma; Fetal anemia; Fetal therapy; Fetal transfusion.

Publication types

  • Case Reports

MeSH terms

  • Anemia* / complications
  • Anemia* / therapy
  • Blood Transfusion, Intrauterine
  • Female
  • Fetus
  • Hemangioma* / complications
  • Hemangioma* / therapy
  • Humans
  • Hydrops Fetalis / diagnostic imaging
  • Hydrops Fetalis / etiology
  • Hydrops Fetalis / therapy
  • Infant, Newborn
  • Placenta Diseases*
  • Pregnancy